Literature DB >> 35472679

Independent effects of Src kinase and podoplanin on anchorage independent cell growth and migration.

Edward P Retzbach1, Stephanie A Sheehan1, Harini Krishnan2, Haiyan Zheng3, Caifeng Zhao3, Gary S Goldberg1.   

Abstract

The Src tyrosine kinase is a strong tumor promotor. Over a century of research has elucidated fundamental mechanisms that drive its oncogenic potential. Src phosphorylates effector proteins to promote hallmarks of tumor progression. For example, Src associates with the Cas focal adhesion adaptor protein to promote anchorage independent cell growth. In addition, Src phosphorylates Cas to induce Pdpn expression to promote cell migration. Pdpn is a transmembrane receptor that can independently increase cell migration in the absence of oncogenic Src kinase activity. However, to our knowledge, effects of Src kinase activity on anchorage independent cell growth and migration have not been examined in the absence of Pdpn expression. Here, we analyzed the effects of an inducible Src kinase construct in knockout cells with and without exogenous Pdpn expression on cell morphology migration and anchorage independent growth. We report that Src promoted anchorage independent cell growth in the absence of Pdpn expression. In contrast, Src was not able to promote cell migration in the absence of Pdpn expression. In addition, continued Src kinase activity was required for cells to assume a transformed morphology since cells reverted to a nontransformed morphology upon cessation of Src kinase activity. We also used phosphoproteomic analysis to identify 28 proteins that are phosphorylated in Src transformed cells in a Pdpn dependent manner. Taken together, these data indicate that Src utilizes Pdpn to promote transformed cell growth and motility in complementary, but parallel, as opposed to serial, pathways.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  Src kinase; anchorage independence; cancer; cell migration; oncogenic transformation; phosphorylation; podoplanin

Mesh:

Substances:

Year:  2022        PMID: 35472679      PMCID: PMC9233000          DOI: 10.1002/mc.23410

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   5.139


  42 in total

1.  Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.

Authors:  K Hansen; T Farkas; J Lukas; K Holm; L Rönnstrand; J Bartek
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  Off-line high-pH reversed-phase fractionation for in-depth phosphoproteomics.

Authors:  Tanveer S Batth; Chiara Francavilla; Jesper V Olsen
Journal:  J Proteome Res       Date:  2014-11-04       Impact factor: 4.466

Review 3.  Src and podoplanin forge a path to destruction.

Authors:  Harini Krishnan; W Todd Miller; Francisco J Blanco; Gary S Goldberg
Journal:  Drug Discov Today       Date:  2018-08-02       Impact factor: 7.851

4.  Serines in the intracellular tail of podoplanin (PDPN) regulate cell motility.

Authors:  Harini Krishnan; Jhon A Ochoa-Alvarez; Yongquan Shen; Evan Nevel; Meenakshi Lakshminarayanan; Mary C Williams; Maria I Ramirez; W Todd Miller; Gary S Goldberg
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

Review 5.  Phosphorylation of connexin43 induced by Src: regulation of gap junctional communication between transformed cells.

Authors:  Madhuri Pahujaa; Michael Anikin; Gary S Goldberg
Journal:  Exp Cell Res       Date:  2007-09-20       Impact factor: 3.905

6.  Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.

Authors:  A C Maroney; S A Qureshi; D A Foster; J S Brugge
Journal:  Oncogene       Date:  1992-06       Impact factor: 9.867

7.  Cardiovascular anomaly, impaired actin bundling and resistance to Src-induced transformation in mice lacking p130Cas.

Authors:  H Honda; H Oda; T Nakamoto; Z Honda; R Sakai; T Suzuki; T Saito; K Nakamura; K Nakao; T Ishikawa; M Katsuki; Y Yazaki; H Hirai
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

8.  RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.

Authors:  Francesca Pentimalli; Iris M Forte; Luca Esposito; Paola Indovina; Carmelina A Iannuzzi; Luigi Alfano; Caterina Costa; Daniela Barone; Gaetano Rocco; Antonio Giordano
Journal:  Oncogene       Date:  2018-04-02       Impact factor: 9.867

9.  Podoplanin associates with CD44 to promote directional cell migration.

Authors:  Ester Martín-Villar; Beatriz Fernández-Muñoz; Maddy Parsons; Maria M Yurrita; Diego Megías; Eduardo Pérez-Gómez; Gareth E Jones; Miguel Quintanilla
Journal:  Mol Biol Cell       Date:  2010-10-20       Impact factor: 4.138

10.  Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.

Authors:  Jhon A Ochoa-Alvarez; Harini Krishnan; John G Pastorino; Evan Nevel; David Kephart; Joseph J Lee; Edward P Retzbach; Yongquan Shen; Mahnaz Fatahzadeh; Soly Baredes; Evelyne Kalyoussef; Masaru Honma; Martin E Adelson; Mika K Kaneko; Yukinari Kato; Mary Ann Young; Lisa Deluca-Rapone; Alan J Shienbaum; Kingsley Yin; Lasse D Jensen; Gary S Goldberg
Journal:  Oncotarget       Date:  2015-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.